RELMADA THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
RELMADA THERAPEUTICS INC share price today is $5.99, up -2.88%. The stock opened at $6.45 against the previous close of $6.25, with an intraday high of $6.59 and low of $5.85.
RELMADA THERAPEUTICS INC Share Price Chart
RELMADA THERAPEUTICS INC
RELMADA THERAPEUTICS INC Share Price Performance
RELMADA THERAPEUTICS INC Institutional Holdings
RELMADA THERAPEUTICS INC Market Status
RELMADA THERAPEUTICS INC Fundamentals
Market Cap 330.73 M
PB Ratio 46.9494
PE Ratio 0.0
Enterprise Value 430.52 M
Total Assets 94.00 M
Volume 1570553
RELMADA THERAPEUTICS INC Company Financials
About RELMADA THERAPEUTICS INC & investment objective
Company Information Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Organisation Biotechnology
Employees 17
Industry Biotechnology
CEO Dr. Sergio Traversa M.B.A., Pharm.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
RELMADA THERAPEUTICS INC FAQs
What is the share price of RELMADA THERAPEUTICS INC today?
The current share price of RELMADA THERAPEUTICS INC is $5.99.
Can I buy RELMADA THERAPEUTICS INC shares in India?
Yes, Indian investors can buy RELMADA THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy RELMADA THERAPEUTICS INC shares in India?
You can easily invest in RELMADA THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy RELMADA THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of RELMADA THERAPEUTICS INC.
Can I buy fractional shares of RELMADA THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of RELMADA THERAPEUTICS INC?
RELMADA THERAPEUTICS INC has a market cap of $330.73 M.
In which sector does RELMADA THERAPEUTICS INC belong?
RELMADA THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in RELMADA THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of RELMADA THERAPEUTICS INC?
The PE ratio of RELMADA THERAPEUTICS INC is N/A and the PB ratio is 46.95.